Quoin Pharmaceuticals, Ltd., a late-stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion, which is in phase 2 to treat netherton...
18 insider purchases on record · latest filing 2025-10-15.
Insiders have also filed 1 sale transaction at QNRX.